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. Chemical structures of additional compounds used in this work. Figure S2 . Figure S5 . In vitro selectivity of α-cyclosulfate 5 against β-glucosidases. Incubation of 5 (from 30 to 0 μM) in GBA2-expressing Hek293T lysates (GBA2+) and GBA3-expressing Hek293T lysates (GBA3+), followed by labeling of β-glucosidases by 500 nM broad spectrum cyclophellitol-aziridine-BODIPY probe 14 (KY375) 1 Following pre-incubation, 25 µL of this E + I mix was added to 100 µL of substrate solution in the same buffer. GBA1 residual activity was measured using final 0.7 nM concentration of enzyme (cerezyme) and 3.0 mM 4-methylumbeliferone(4MU)-β-D-glucopyranoside, for 30 min at 37 °C. GBA2 residual activity was measured using cellular homogenates of HEK293T over-expressing GBA2 pre-incubated for 30 min with an inhibitor of GBA1 (1 μM  MDW933 2 ), and further incubation with 3.0 mM 4-methylumbeliferone(4MU)-β-Dglucopyranoside for 1 h at 37 °C. GAA activity was measured using final concentrations of 47 nM and 2.4 mM 4MU-α-D-glucopyranoside, for 1 h at 37 °C. GANAB activity was measured using fibroblasts of Pompe patients diagnosed on the basis of absence GAA activity and 2.4 mM 4MU-α-D-glucopyranoside, for 2 h at 37 °C. TmGH1 and TxGH116 residual activity was measured using final concentrations of 0.1 nM and 0.2 nM respectively and 3.0 mM 4MU-β-D-glucopyranoside, for 30 min at 25 °C. CjAgd31B residual activity was measured using final concentrations of 6.5 μM and 2. 
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Kinetic studies
Enzyme and relevant inhibitor dilutions were pre-incubated for 0.5, 2, 3. Wet slab-gels were scanned for ABP-emitted fluorescence using a Typhoon FLA9500 imager (GE) with the following settings: λ EX ≥ 473 nm, λ EM ≥510 nm, for 14, and λ EX ≥ 635 nm, λ EM ≥665 nm for 13.
Labeling protocols
Generation of stable GBA2-and GBA3-expressing Hek293T: The PCR-amplified human GBA2 (GBA2, acc. nr: NM_020944.2) coding sequence (using the following oligonucleotides: sense 5'-GGGGACAAGTTTGTACAAAAAAGCAGGCTTAACCACCA TGGGGACCCAGGATCCAG-3' and antisense 5'-GGGGACCACTTTGTACAAGAAAGC TGGGTTTCACTCTGGGCTCAGGTTTG-3') was cloned into pDNOR-221 and sub-cloned in pLenti6.3/TO/V5-DEST using the Gateway system (Invitrogen). Correctness of the construct was verified by sequencing. To produce lentiviral particles Hek293T cells were transfected with pLenti6.3-GBA2 in combination with the envelope and packaging plasmids pMD2G, pRRE and pRSV. Subsequently, culture supernatant containing viral particles was collected and used for infection of Hek293T cells. Selection using blasticidin for several weeks rendered cells stably expressing human GBA2 as determined by activity assays and activity based probes (data not shown).
For human GBA3 the PCR-amplified GBA3 (GBA3, acc. Nr: NM_020973.4) coding sequence using the following oligonucleotides: sense. 5'-GAATTCGCCGCCACCATGGCTTTCCCTGCAGGATTTG-3' and antisense 5'-GCGGCCGCAGATGTGCTTCAAGGCCATTG-3') was cloned in pcDNA3.1/Zeo and transfected into Hek293T cells using FuGENE® 6 Transfection Reagent (Promega Benelux, Leiden, The Netherlands). Selection using Zeocin for several weeks rendered cells stably expressing human GBA3 as determined by activity assays and Activity based probes (data not shown).
In vitro selectivity of α-cyclosulfate 5 vs β-glucosidases: Cells were pelleted and lysed in Kpi buffer (25 mM K 2 HPO 4 -KH 2 PO 4 , pH 6.5, 0.1% (v/v) Triton X-100 and protease inhibitor cocktail (Roche, (version 12)) for 1 h on ice and vortexing. Protein concentrations were S14 measured by BCA assay (Pierce BCA kit, Thermo Fisher). For labeling, 20 µg total protein from the lysate were equilibrated with 750 mM McIlvaine buffer to pH 5.8 (GBA2 labeling) or 6.0 (GBA3 labeling) in a total volume of 10 µL. The samples were treated with 5 at various concentrations for 1h at 37 °C (prepared as 5x stock solutions in 2.5 µL McIlvaine buffer pH 5.8 or 6.0), followed by incubation with 500 nM of probe 14 for 30 min at 37 °C (prepared as 6x stock solution in 2.5 µL McIlvaine buffer pH 5.8 or 6.0). Samples were boiled with 5x Laemmli's sample buffer for 5 min at 98°C, resolved with 10% SDS-PAGE, and scanned for Cy2 (λ EX ≥ 473 nm, λ EM ≥ 510 nm) and Cy5 (λ EX ≥ 635 nm, λ EM ≥ 665 nm) fluorescence on a Typhoon FLA9500 Imager (GE). Coomassie Brilliant Blue was used for loading control, and the stained gel was imaged by a ChemiDoc MP Imager (Bio-Rad).
Stability of cyclosulfate 5 and 6
Compounds 5 (1.32 mg) and 6 (1.66 mg) were dissolved in a total volume of 0.5 mL of 10% D2O and 90%150 mM McIlvaine buffer pH 4.0 and left at room temperature. 1H NMR was registered after 0.5, 2.5, 4.5, 6, 8 and 24 h, showing no acidic hydrolysis after 24 h ( Figure  S3 ).
Molecular Modeling
The free energy landscapes of the four cyclophellitol sulfates (1,6-epi-cyclophellitol cyclosulfate 5 and cyclophellitol cyclosulfate 6 were obtained by means of quantum mechanical calculations, using Density Functional Theory-based molecular dynamics (MD), according to the Car-Parrinello method. 6 All systems were enclosed in an isolated cubic box of 12.0 Å x 12.0 Å x 12.0 Å, using a fictitious electron mass of 700 au and a time step of 0.12 fs. The Kohn-Sham orbitals were expanded in a plane wave (PW) basis set with a kinetic energy cutoff of 70 Ry. Ab initio pseudopotentials generated within the Troullier-Martins scheme were employed. 7 The Perdew, Burke and Ernzerhoff generalized gradient-corrected approximation (PBE) 8 was selected in view of its good performance in previous work on isolated sugars, 9, 10 glycosidases 11 and glycosyltransferases. 12 The metadynamics algorithm 13, 14 was used to explore the conformational free energy landscape of all systems, taking as collective variables θ and φ of the puckering coordinates of Cremer and Pople. 15 Initially, the height of these Gaussian terms was set at 0.6 kcal·mol-1 and a new Gaussian-like potential was added every 30 fs. Once the whole free energy space was explored, the height of the Gaussian terms was reduced to the half (0.3 kcal·mol -1 ) and a new Gaussian-like potential was added every 60 fs. The width of the Gaussian terms was set to 0.10 Å. The free energy landscape of each molecule was fully explored in less than 60 ps and the simulations were further extended up to 140 ps, when convergence was achieved according to the invariance of the energy differences between the principal wells (standard deviation < 1 kcal·mol-1, considering the last 20 ps of simulation).
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Crystallographic data collection and refinement
Agd31B wt and D412N mutant
Wild type CjAgd31B expression and purification was carried out as previously described. For mutant CjAgd31B complexes with unreacted 4 and 5, ligands were modeled at 0.7 occupancy due to weaker ligand binding to the mutant enzyme. For the mutant CjAgd31B complex with unreacted 4, the displayed F c -F o map was calculated by refinement without a bulk solvent mask, which improved difference density for the ligand. All ligand coordinates were built using jLigand 23 . Ligand ring conformations were analyzed using Privateer 24 .
Crystal structure figures were generated using Pymol.
TxGH116
TxGH116 expression and purification was carried out as previously described 4 .
Crystals of TxGH116 were obtained by the sitting drop vapor diffusion method at 20 °C using 0.1 M BisTris pH 5.5 -6.7, 0.2 M ammonium sulfate, 20% PEG 3350. Unreacted complexes with 6 were obtained by soaking TxGH116 crystals with 6 (at 5 mM) in mother liquor solution for 10-20 min at 20 °C, before transferring to cryoprotectant solution (mother liquor supplemented with 25% ethylene glycol) and flash freezing in liquid N 2 for data collection. Reacted complexes with 6 were obtained by soaking TxGH116 crystals with 6 (at 5 mM) in mother liquor solution for ~24 h at 20 °C, before transferring cryoprotectant solution and flash freezing in liquid N 2 for data collection.
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Data were collected at beamline I02 of the Diamond light source. Processing, model building and refinements were carried out as described above for CjAgd31B. S17
Chemical synthesis General Experimental Details
All reagents were of a commercial grade and were used as received unless stated otherwise. Dichloromethane (DCM), tetrahydrofuran (THF) and N,N-dimethylformamide (DMF) were stored over 4 Å molecular sieves, which were dried in vacuo before use. Triethylamine was dried over KOH and distilled before using. All reactions were performed under an argon atmosphere unless stated otherwise. Solvents used for flash column chromatography were of pro analysis quality. Reactions were monitored by analytical thin-layer chromatography (TLC) using Merck aluminum sheets pre-coated with silica gel 60 with detection by UV absorption (254 nm) and by spraying with a solution of (NH 4 (600/150 MHz) and Bruker AV-400 (400/100 MHz) spectrometer in the given solvent. Chemical shifts are given in ppm relative to the chloroform residual solvent peak or tetramethylsilane (TMS) as internal standard. Coupling constants are given in Hz. All given 13 C spectra are proton decoupled. The following abbreviations are used to describe peak patterns when appropriate: s (singlet), d (doublet), t (triplet), qt (quintet), m (multiplet), br (broad), ar (aromatic), app (apparent). 2D NMR experiments (HSQC, COSY and NOESY) were carried out to assign protons and carbons of the new structures and assignation follows the general numbering shown in cyclohexene 8. High-resolution mass spectra (HRMS) of intermediates were recorded with a LTQ Orbitrap (Thermo Finnigan) and final compounds were recorded with a apex-QE instrument (Bruker). Optical rotations were measured on a Anton Paar MCP automatic polarimeter (Sodium D-line, λ = 589 nm). LC/MS analysis was performed on an LCQ Advantage Max (Thermo Finnigan) ion-trap spectrometer (ESI+) coupled to a Surveyor HPLC system (Thermo Finnigan) equipped with a C18 column (Gemini, 4.6 mm x 50 mm, 3 μm particle size, Phenomenex) equipped with buffers A: H 2 O, B: acetonitrile (MeCN) and C: 1% aqueous TFA or 50 mM NH 4 28 were synthesized following procedures previously described and their spectroscopic data are in agreement with those previously reported.
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Synthesis and Characterization Data of Compounds 5 and 6.
[
({(1R,2R,5S,6R)-5,6-bis(benzyloxy)-2-[(benzyloxy)methyl]cyclohex-3-en-1-yl}oxy)methyl] benzene (8).
Catalytic amount of TBAI (54 mg, 0.15 mmol), BnBr (0.87 mL, 7.34 mmol) and sodium hydride (60% dispersion in mineral oil, 294 mg, 7.3 mmol) were added to a solution of 7 (500 mg, 1.47 mmol) in DMF (60 mL) at 0 ºC and the reaction mixture was stirred at room temperature overnight. The reaction mixture was cooled to 0 °C and quenched by the addition of MeOH. The mixture was further diluted with water and subsequently extracted with EtOAc. The organic phase was washed with brine, dried over MgSO 4 , filtered, and concentrated in vacuo. The crude was purified by silica column chromatography (from pentane to pentane/EtOAc 9:1) to afford the desired product 11 (538 mg, 70%) as a colourless oil. A solution of sodium metaperiodate (319 mg, 1.49 mmol) and catalytic amount of ruthenium trichloridetrihydrate (18.2 mg, 0.07 mmol) in water (8 mL) was added to a vigorously stirred ice-cooled solution of diene 8 (518 mg, 1.0 mmol) in EtOAc/ACN 1:1 (30 mL). The stirring was continued at 0ºC for 2h. The reaction was then quenched by addition of 10% aqueous Na 2 S 2 O 3 solution (10 mL). The aqueous layer was separated and extracted three times with ethyl acetate (3 x 20 mL). The combined organic extracts were washed with brine, dried with MgSO 4 and concentrated under reduced pressure. The crude was purified by silica column chromatography (Pentane/EtOAc from 9:1 to 3:7) to afford 9 ( 215 mg, 0.39 mmol, 39%) and 10 (142 mg, 0.26 mmol, 26%). 
General Procedure for the Synthesis of Cyclosulfates.
Thionyl chloride (3.5 equiv. for cis and 7 equiv. for trans diol) was added over 5 min to a solution of diol (1 equiv.) and triethylamine (4 equiv. for cis and 8 equiv. for trans diol) in DCM (50 mL/mmol) at 0 °C. The reaction mixture was diluted with cold diethyl ether and washed with cold water and brine. The organic phase was dried (MgSO 4 ), filtered, concentrated under reduced pressure, and the residual triethylamine was removed under high vacuum (1 h).
The resulting oil was dissolved in CCl 4 (40 mL/mmol) and ACN (40 mL/mmol), and the solution was cooled to 0 °C in an ice-bath. A solution of catalytic amount of RuCl 3 ·3H 2 O (0.1 equiv.) and NaIO 4 (2 equiv.) in water (40 mL/mmol) was added and the reaction mixture was stirred at 0 °C for 3 h. Diethyl ether was added and the two layers were separated. The aqueous phase was extracted again with diethyl ether and the combined organic extracts were washed with brine and dried over MgSO 4 . The crude was concentrated under reduced pressure and purified by silica column chromatography (from Pentane to Pentane/EtOAc to 8:2) to afford the desired intermediates. 
General Procedure for the Deprotection of Cyclosulfates.
10% Palladium on carbon (0.4 equiv.) was added to a solution of intermediates 11 and 12 (1 equiv.) in MeOH (50 mL/mmol) under argon atmosphere. The mixture was hydrogenated with a hydrogen balloon and stirred under hydrogen atmosphere for 18 h. Then, the reaction mixture was filtered through a celite plug and the solvent was evaporated under reduced pressure. The crude was purified by chromatography (from DCM to DCM/MeOH 9:1) to afford the desired final products 5 and 6. biosyn1Hfast MeOD /opt/DATA nmrafd 13 
